Drug Type Radiolabeled antibody, Diagnostic radiopharmaceuticals |
Synonyms Anticancer monoclonal antibody A33, huA33 antibody, 124I-HUA33 + [2] |
Target |
Action inhibitors, enhancers |
Mechanism GPA33 inhibitors(Cell surface A33 antigen inhibitors), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Colorectal Carcinoma | Phase 1 | Germany | 18 Apr 2005 | |
Metastatic Colorectal Carcinoma | Phase 1 | Switzerland | 18 Apr 2005 |
Phase 1 | 20 | xeoaaewmgk = yxaqyowcqs nsqvibmkxa (xsjmrrykmg, jinwtmscfc - dihuklsopi) View more | - | 16 Jun 2021 | |||
Phase 1 | 19 | uejfjmqdvq(yhjpugbsdl) = dadrtnaqem ljcdsdklxw (xzjwzoyqdc ) | - | 20 Jun 2007 |